Richmond Pharmacology   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: London United Kingdom (2001)

Organization Overview

First Clinical Trial
2006
NCT00369031
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Richmond Phamacology, LTD | Richmond Pharmacology | Richmond Pharmacology Limited | Richmond Pharmacology Ltd CEO | Richmond Pharmacology Ltd St George's University of London Cranmer Terrace, TootingLondon SW17 ORE UK | Richmond Pharmacology Ltd, UK